BDX.AX ASX
BCAL Diagnostics Limited
1W: +7.4%
1M: +26.1%
3M: +20.8%
YTD: -27.5%
1Y: +33.9%
3Y: -11.2%
5Y: -56.5%
A$0.09 ($0.06)
+0.00 (+4.60%)
Weekly Expected Move ±16.7%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$6M
-0.4% ▼
Capital Expenditures
$459K
+41.7% ▲
5Y CAGR: +160.2%
Free Cash Flow
-$7M
+4.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$3M
-50.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$5M | -$6M | $0 | -$7M |
| Depreciation & Amort. | $21K | $114K | $580K | $0 | $717K |
| Stock-Based Comp. | $370K | $226K | $573K | $0 | $0 |
| Change in Working Capital | -$239K | -$1M | $611K | -$573K | -$8K |
| Other Non-Cash Items | $384K | $265K | $113K | -$6M | $502K |
| Operating Cash Flow | -$3M | -$6M | -$5M | -$6M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$4M | -$362K | -$1M | -$788K | -$459K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $302K |
| Investment Purchases | -$4M | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $4M | $0 | $0 | $0 |
| Other Investing | $4M | $0 | $0 | $0 | -$1M |
| Investing Cash Flow | -$4M | $4M | -$1M | -$788K | -$1M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$37K | -$257K | $1M | -$179K |
| Stock Repurchased | -$622K | $0 | -$445K | -$115K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $101K | -$295K | $5M |
| Financing Cash Flow | $9M | $13K | $9M | $5M | $5M |
| Net Change in Cash | $2M | -$2M | $3M | -$2M | -$3M |
| Cash End of Period | $6M | $3M | $6M | $5M | $2M |
| Free Cash Flow | -$7M | -$6M | -$6M | -$7M | -$7M |